FSTX
Goldman Sachs’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-104,690
| Closed | -$662K | – | 5408 |
|
|
2022
Q4 | $662K | Buy |
104,690
+30,582
| +41% | +$193K | ﹤0.01% | 3932 |
|
|
2022
Q3 | $379K | Buy |
74,108
+53,962
| +268% | +$276K | ﹤0.01% | 4414 |
|
|
2022
Q2 | $126K | Sell |
20,146
-13,656
| -40% | -$85.4K | ﹤0.01% | 5050 |
|
|
2022
Q1 | $120K | Buy |
+33,802
| New | +$120K | ﹤0.01% | 5254 |
|
|
2019
Q3 | – | Sell |
-98,509
| Closed | -$363K | – | 4367 |
|
|
2019
Q2 | $363K | Buy |
+98,509
| New | +$363K | ﹤0.01% | 3640 |
|
|
2018
Q3 | – | Sell |
-23,284
| Closed | -$276K | – | 4279 |
|
|
2018
Q2 | $276K | Buy |
23,284
+9,356
| +67% | +$111K | ﹤0.01% | 3760 |
|
|
2018
Q1 | $214K | Buy |
+13,928
| New | +$214K | ﹤0.01% | 3827 |
|
|
2017
Q2 | – | Sell |
-20,249
| Closed | -$180K | – | 4561 |
|
|
2017
Q1 | $180K | Buy |
+20,249
| New | +$180K | ﹤0.01% | 3982 |
|